中生北控生物科技(08247)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

08247 中生北控生物科技

休市中 07-17 15:41:02

2.990

+0.160

+5.65%

最高2.990	最低2.790	成交量5.80万
今开2.820	昨收2.830	日振幅7.07%
总市值4.33亿	流通市值1.92亿	总股本1.45亿
成交额16.66万	换手率0.09%	流通股本6,429万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"08247","market":"HK","secType":"STK","nameCN":"中生北控生物科技","latestPrice":2.99,"timestamp":1784274062552,"preClose":2.83,"halted":0,"volume":58000,"delay":0,"changeRate":0.05653710247349828,"floatShares":64286143,"shares":144707176,"eps":-0.353,"marketStatus":"休市中","change":0.16,"latestTime":"07-17 15:41:02","open":2.82,"high":2.99,"low":2.79,"amount":166640,"amplitude":0.070671,"askPrice":3,"askSize":6000,"bidPrice":2.85,"bidSize":6000,"shortable":0,"etf":0,"ttmEps":-0.393286,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1784511000000},"marketStatusCode":7,"adr":0,"listingDate":1140969600000,"exchange":"SEHK","adjPreClose":2.83,"openAndCloseTimeList":[[1784251800000,1784260800000],[1784264400000,1784275200000]],"volumeRatio":0.417867,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/08247/tweets","defaultTab":"tweets","newsList":[{"id":"1159603241","title":"中生北控生物科技(08247)主席陈鹏增持430.02万股 内资股持股比例升至19.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=1159603241","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159603241?lang=zh_cn&edition=full","pubTime":"2026-07-16 18:45","pubTimestamp":1784198728,"startTime":"0","endTime":"0","summary":"中生北控生物科技股份有限公司7月16日公告称，公司主席、总裁、执行董事及主要股东陈鹏于2026年6月15日至2026年7月14日期间，通过景宁国科康仪企业管理中心及国科健康院创新研究院（合肥）合伙企业，以总代价约人民币10.53百万元，场外合共购入4,300,176股公司内资股，收购价格介乎每股人民币2.40元至人民币2.50元，该笔增持占公司已发行股份总数的2.97%。公司表示，将持续关注陈鹏的持股变化并按规定履行信息披露义务。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08247"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175258582","title":"中生北控生物科技收购案总对价1.053亿元 每股作价介于2.40至2.50元","url":"https://stock-news.laohu8.com/highlight/detail?id=1175258582","media":"美股速递","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1175258582?lang=zh_cn&edition=full","pubTime":"2026-07-16 18:42","pubTimestamp":1784198524,"startTime":"0","endTime":"0","summary":"中生北控生物科技公司一项收购交易的总对价确定为人民币1.053亿元，每股收购价格区间设定在人民币2.40元至2.50元之间。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","08247"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651445260","title":"中生北控生物科技(08247.HK)获主要股东陈鹏增持约430.02万股公司内资股","url":"https://stock-news.laohu8.com/highlight/detail?id=2651445260","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651445260?lang=zh_cn&edition=full","pubTime":"2026-07-16 18:42","pubTimestamp":1784198523,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","08247"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195224305","title":"中生北控生物科技、元臻投资及自然人终止一致行动协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1195224305","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1195224305?lang=zh_cn&edition=full","pubTime":"2026-07-03 18:53","pubTimestamp":1783076021,"startTime":"0","endTime":"0","summary":"中生北控生物科技股份有限公司、元臻投资及一位自然人已共同决定，终止就中生金域相关事项所达成的一致行动协议。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","08247"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125049139","title":"中生北控生物科技6月股份变动月报表，股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1125049139","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1125049139?lang=zh_cn&edition=full","pubTime":"2026-07-02 17:23","pubTimestamp":1782984185,"startTime":"0","endTime":"0","summary":"中生北控生物科技股份有限公司于2026年7月2日发布2026年6月股份变动月报表。根据公告显示，公司法定/注册股本合计为人民币144,707,176元，分为64,286,143股H股及80,421,033股内资股，全部股本面值为每股人民币1元。报告期内，公司已发行股份数与股本总额均保持不变，未发生新增发行、购回及注销或库藏股变动。截至2026年6月30日，该公司H股发行总数为64,286,143股，内资股发行总数为80,421,033股，均与上个月保持一致，库存股份数目为零，股本仍维持稳定。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08247"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647302205","title":"中生北控生物科技(08247.HK)将采用中国企业会计准则编制财务会计报告 终止委任香港立信德豪为国际核数师","url":"https://stock-news.laohu8.com/highlight/detail?id=2647302205","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647302205?lang=zh_cn&edition=full","pubTime":"2026-06-30 19:09","pubTimestamp":1782817756,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","08247"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647530769","title":"中生北控生物科技：国际核数师辞任","url":"https://stock-news.laohu8.com/highlight/detail?id=2647530769","media":"南方财经网","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647530769?lang=zh_cn&edition=full","pubTime":"2026-06-30 19:05","pubTimestamp":1782817500,"startTime":"0","endTime":"0","summary":"南财智讯6月30日电，中生北控生物科技（08247.HK）公告，香港立信德豪会计师事务所有限公司已辞任公司国际核数师，自2026年6月25日起生效。此次辞任系因公司董事会于2026年6月25日批准自2026年中期业绩及中期财务报告起采用中国企业会计准则编制财务会计报告，不再需要国际核数师服务。立信会计师事务所（特殊普通合伙）将继续担任公司中国核数师。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606303788502830.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["08247","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191203043","title":"中生北控生物科技5月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1191203043","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1191203043?lang=zh_cn&edition=full","pubTime":"2026-06-01 17:21","pubTimestamp":1780305685,"startTime":"0","endTime":"0","summary":"中生北控生物科技股份有限公司于2026年6月1日发布5月股份变动月报表，报告期截至2026年5月31日。该公司成立于中华人民共和国，为股份有限公司。根据公告，截至5月31日，公司法定/注册股本总额约为人民币1.45亿元，相应股本结构保持不变。上述数据显示当月公司股本结构无变化，发行股份数目维持稳定。公告显示，公司已符合香港联交所GEM上市规则要求的公众持股量标准。该月报表由公司秘书董渙樟签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08247"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188943509","title":"中生北控生物科技4月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1188943509","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1188943509?lang=zh_cn&edition=full","pubTime":"2026-05-04 16:47","pubTimestamp":1777884435,"startTime":"0","endTime":"0","summary":"中生北控生物科技股份有限公司（股票代码：08247）于2026年5月4日发布2026年4月股份变动月报表，报告期内公司股本总数稳定，未发生新增发行、购回、注销或库藏股变动。\n公司披露，截至4月30日，公司注册股本总额144,707,176股，其中包括H股64,286,143股，以及内资股80,421,033股，两类股份数量均与上月底保持一致。公司同时确认当月无任何股份期权、可换股票据或其他形式的已发行股份变动。\n报告显示，4月底公司已发行股份及公眾持股量符合香港联交所相关要求。此外，公告由公司秘书董渙樟签署，确认遵守香港联交所《上市规则》及相关法律法规。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08247"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628721959","title":"中生北控生物科技(08247)附属中生济南自主研发的ZS-2000全自动生化分析仪获发医疗器械注册证上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2628721959","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628721959?lang=zh_cn&edition=full","pubTime":"2026-04-20 22:36","pubTimestamp":1776695791,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中生北控生物科技 发布公告，公司的附属公司中生医疗器械科技(济南)有限公司自主研发的ZS-2000全自动生化分析仪，近日已获得中国山东省药品监督管理局颁发的中国医疗器械注册证。此外，董事会认为，ZS-2000全自动生化分析仪的成功上市，并合作推出ZS-8600生化免疫一体机，有助于集团进一步拓展国内医疗检测市场，推动相关配套试剂产品销售，符合集团长远发展战略。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1430983.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["08247","BK1574","159883","BK1583","IPOS","09997","BK1161","BK1222","BK1100","09996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126913752","title":"中生北控生物科技全自动生化分析仪ZS-2000获中国医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=1126913752","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126913752?lang=zh_cn&edition=full","pubTime":"2026-04-20 22:34","pubTimestamp":1776695657,"startTime":"0","endTime":"0","summary":"中生北控生物科技股份有限公司宣布，其自主研发的ZS-2000全自动生化分析仪已正式获得中国国家药品监督管理局颁发的医疗器械注册证书。这一重要资质的取得，标志着该产品符合中国市场准入标准，为后续规模化商业推广奠定了坚实基础。\n作为一款高性能的临床检测设备，ZS-2000全自动生化分析仪能够实现生化指标的快速、精准检测，可广泛应用于各级医疗机构的检验科室。此次获批不仅体现了公司在体外诊断领域的技术实力，也有助于进一步丰富其产品管线，提升市场竞争力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08247","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180567344","title":"中生北控生物科技2026年3月股份变动月报，股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1180567344","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1180567344?lang=zh_cn&edition=full","pubTime":"2026-04-01 14:15","pubTimestamp":1775024157,"startTime":"0","endTime":"0","summary":"中生北控生物科技股份有限公司（股票代码：08247）于2026年4月1日发布2026年3月股份变动月报。报告期截至2026年3月31日，普通股H股数量为64,286,143股，内资股数量为80,421,033股，合计144,707,176股。上述各类股份本月均无新增发行或回购注销等变动，股本维持不变。\n公告还显示，报告期内无任何股份期权、可换股票据或其他权益性工具的发行或变动。公司确认目前已符合香港联交所相关公众持股量要求，遵守了《上市规则》的各项规定。\n本次月报由公司秘书董渙樟签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08247"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159635658","title":"中生北控生物科技(08247)2025财年收入下滑、亏损扩大，持续深化IVD多元化战略","url":"https://stock-news.laohu8.com/highlight/detail?id=1159635658","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159635658?lang=zh_cn&edition=full","pubTime":"2026-03-31 21:17","pubTimestamp":1774963026,"startTime":"0","endTime":"0","summary":"中生北控生物科技于2025财年的整体经营业绩出现下滑，财务数据显示，截至2025年3月31日止年度营业收入为人民币1.843亿元，较上一财年约人民币2.631亿元下降30%，年度亏损从上一财年的人民币5,690万元扩大至约人民币6,500万元。公司管理层表示，体外诊断行业在技术快速迭代与市场竞争加剧的背景下持续洗牌，公司在此期间的业务规模与盈利能力均受到一定冲击。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08247"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623847695","title":"中生北控生物科技(08247)发布年度业绩，股东应占亏损5114.2万元 同比增加20.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2623847695","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623847695?lang=zh_cn&edition=full","pubTime":"2026-03-31 21:08","pubTimestamp":1774962503,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中生北控生物科技(08247)发布截至2025年12月31日止年度业绩，该集团取得营业收入1.843亿元，同比减少30%;母公司拥有人应占亏损5114.2万元，同比增加20.24%;每股亏损0.353元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1423305.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"中生北控生物科技(08247)发布年度业绩，股东应占亏损5114.2万元 同比增加20.24%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","08247"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149172522","title":"中生北控生物科技（08247）2月股份变动月报：股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1149172522","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1149172522?lang=zh_cn&edition=full","pubTime":"2026-03-02 14:22","pubTimestamp":1772432550,"startTime":"0","endTime":"0","summary":"2026年3月2日，中生北控生物科技股份有限公司发布截至2026年2月28日的股份变动月报。公告显示，公司本月内并无新增发行、购回或注销股份，整体股本结构保持稳定。报告期内，各类股份数量均无变动，公司确认符合香港联交所对公众持股量的最低要求。公司表示，当前已发行股份合计144,707,176股，所有股份于本月月底保持不变。公司声明遵守香港联交所《上市规则》及相关法律法规。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08247"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614063437","title":"中生北控生物科技02月25日主力净流出34.9万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2614063437","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614063437?lang=zh_cn&edition=full","pubTime":"2026-02-25 16:15","pubTimestamp":1772007350,"startTime":"0","endTime":"0","summary":"02月25日，中生北控生物科技股价收平报5.83元，成交金额222.0万元，换手率0.59%，振幅4.12%，量比1.54。中生北控生物科技今日主力资金净流出34.9万元，上一交易日主力净流出0万元。该股近5个交易日上涨15.22%，主力资金累计净流出34.9万元；近20日主力资金累计净流出238.5万元，其中净流出天数为5日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225162008a71d4a7d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225162008a71d4a7d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["08247","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612679092","title":"中生北控生物科技盘中异动 早盘股价大跌6.43%报5.240港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2612679092","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612679092?lang=zh_cn&edition=full","pubTime":"2026-02-20 10:28","pubTimestamp":1771554538,"startTime":"0","endTime":"0","summary":"2026年02月20日早盘10时28分，中生北控生物科技股票出现波动，股价大幅跳水6.43%。截至发稿，该股报5.240港元/股，成交量2.8万股，换手率0.04%，振幅6.43%。资金方面，该股资金流入8.848万港元，流出8.566万港元。中生北控生物科技股票所在的生物技术行业中，整体涨幅为1.39%。中生北控生物科技公司简介：中生北控生物科技股份有限公司是一家主要从事体外诊断试剂产品研发、制造、销售及分销业务的中国公司。该公司产品销往医院及医疗机构。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022010285895417e0f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022010285895417e0f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["08247","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2611813478","title":"中生北控生物科技(08247)附属中生医疗自主研发的BioCyte 系列流式细胞仪获发马来西亚医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2611813478","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611813478?lang=zh_cn&edition=full","pubTime":"2026-02-13 16:43","pubTimestamp":1770972201,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中生北控生物科技 发布公告，本公司的附属公司中生(苏州)医疗科技有限公司自主研发的BioCyte 系列流式细胞仪，近日成功通过马来西亚医疗器械管理局的审核，正式获得马来西亚医疗器械注册证，注册编号为IVDA9463526–225393。BioCyte系列流式细胞仪凭藉稳定性能及检测准确性，已在国内市场获得应用。中生医疗依据当地相关法规要求，完成产品检测、技术资料提交及审核程式，最终获得马来西亚医疗器械管理局批准。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1405173.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["08247","BK1161","BK1574","09997","BK1583","159891","09996","159883","BK1222","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148551939","title":"中生北控生物科技于马来西亚获得医疗器械注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=1148551939","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1148551939?lang=zh_cn&edition=full","pubTime":"2026-02-13 16:34","pubTimestamp":1770971680,"startTime":"0","endTime":"0","summary":"中生北控生物科技股份有限公司（股票代码：08247）近日宣布，其产品已成功获得马来西亚颁发的医疗器械注册证书。这一重要进展标志着公司产品在马来西亚市场的准入资格得到正式认可，为其国际化战略迈出了关键一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08247","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139078278","title":"中生北控生物科技拟战略投资广东小寿医疗科技等公司","url":"https://stock-news.laohu8.com/highlight/detail?id=1139078278","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139078278?lang=zh_cn&edition=full","pubTime":"2026-02-11 18:10","pubTimestamp":1770804655,"startTime":"0","endTime":"0","summary":"根据协议安排，中生北控生物科技股份有限公司计划对广东小寿医疗技术有限公司及其他相关企业进行战略性股权投资。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","08247"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.zhongsheng.com.cn","stockEarnings":[{"period":"1week","weight":0.3468},{"period":"1month","weight":0.0346},{"period":"3month","weight":-0.1358},{"period":"6month","weight":-0.1671},{"period":"1year","weight":2.8333},{"period":"ytd","weight":0.323}],"compareEarnings":[{"period":"1week","weight":0.016},{"period":"1month","weight":0.0103},{"period":"3month","weight":-0.0611},{"period":"6month","weight":-0.085},{"period":"1year","weight":0.0026},{"period":"ytd","weight":-0.0417}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"中生北控生物科技股份有限公司是一家主要从事研发、生产、销售及分销体外诊断试剂的中国公司。该公司的主要产品包括临床化学、免疫诊断产品、分子诊断产品、血液诊断产品、医学临床营养诊断产品及相关分析仪器及原料。该公司的产品主要用于肝功能、血脂、肾功能、心肌、特殊蛋白、微量元素、糖代谢等诊断。该公司主要在国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.043754},{"month":2,"riseRate":0.444444,"avgChangeRate":0.04506},{"month":3,"riseRate":0.578947,"avgChangeRate":0.033322},{"month":4,"riseRate":0.35,"avgChangeRate":-0.004864},{"month":5,"riseRate":0.45,"avgChangeRate":0.040423},{"month":6,"riseRate":0.25,"avgChangeRate":-0.054052},{"month":7,"riseRate":0.4,"avgChangeRate":-0.043654},{"month":8,"riseRate":0.473684,"avgChangeRate":0.052752},{"month":9,"riseRate":0.444444,"avgChangeRate":0.00658},{"month":10,"riseRate":0.368421,"avgChangeRate":0.002429},{"month":11,"riseRate":0.526316,"avgChangeRate":0.066742},{"month":12,"riseRate":0.421053,"avgChangeRate":0.016056}],"exchange":"SEHK","name":"中生北控生物科技","nameEN":"BIOSINO BIO-TEC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"中生北控生物科技(08247)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供中生北控生物科技(08247)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"中生北控生物科技,08247,中生北控生物科技股票,中生北控生物科技股票老虎,中生北控生物科技股票老虎国际,中生北控生物科技行情,中生北控生物科技股票行情,中生北控生物科技股价,中生北控生物科技股市,中生北控生物科技股票价格,中生北控生物科技股票交易,中生北控生物科技股票购买,中生北控生物科技股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"中生北控生物科技(08247)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供中生北控生物科技(08247)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}